PBPK Modeling to Simulate the Fate of Compounds in Living Organisms.

Methods Mol Biol

INERIS, Unit of Experimental Toxicology and Modelling, Verneuil en Halatte, France.

Published: February 2022

Pharmacokinetics study the fate of xenobiotics in a living organism. Physiologically based pharmacokinetic (PBPK) models provide realistic descriptions of xenobiotics' absorption, distribution, metabolism, and excretion processes. They model the body as a set of homogeneous compartments representing organs, and their parameters refer to anatomical, physiological, biochemical, and physicochemical entities. They offer a quantitative mechanistic framework to understand and simulate the time-course of the concentration of a substance in various organs and body fluids. These models are well suited for performing extrapolations inherent to toxicology and pharmacology (e.g., between species or doses) and for integrating data obtained from various sources (e.g., in vitro or in vivo experiments, structure-activity models). In this chapter, we describe the practical development and basic use of a PBPK model from model building to model simulations, through implementation with an easily accessible free software.

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-0716-1960-5_2DOI Listing

Publication Analysis

Top Keywords

pbpk modeling
4
modeling simulate
4
simulate fate
4
fate compounds
4
compounds living
4
living organisms
4
organisms pharmacokinetics
4
pharmacokinetics study
4
study fate
4
fate xenobiotics
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!